La Jolla Spa MD, Inc. et al v. Avidas Pharmaceuticals, LLC et al

Filing 86

ORDER Granting #77 Plaintiff's Motion for Leave to File Third Amended Complaint. Plaintiff has met the requirements of Federal Rules of Civil Procedure 15(a) and 16(b). Accordingly, the Court grants Plaintiff's motion. The Clerk of Court is instructed to file Plaintiff's proposed Third Amended Complaint (Doc. No. 77-7) as a separate docket entry. Signed by Judge Michael M. Anello on 4/29/2019. (rmc)

Download PDF
1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 LA JOLLA SPA MD, INC., Case No.: 17cv1124-MMA (WVG) Plaintiff, 12 13 v. 14 ORDER GRANTING PLAINTIFF'S MOTION FOR LEAVE TO FILE THIRD AMENDED COMPLAINT AVIDAS PHARMACEUTICALS, LLC, Defendant. 15 [Doc. No. 77] 16 17 Plaintiff La Jolla Spa MD, Inc. (“Plaintiff”) has moved the Court for leave to file a 18 Third Amended Complaint (“TAC”). Doc. No. 77-1 (“Mtn.”). Defendant Avidas 19 Pharmaceuticals, LLC (“Defendant”) filed a response in opposition [Doc. No. 83 20 (“Oppo.”)], to which Plaintiff replied [Doc. No. 84 (“Reply”)]. The Court found the 21 matter suitable for determination on the papers and without oral argument pursuant to 22 Civil Local Rule 7.1.d.1. Doc. No. 85. For the reasons set forth below, the Court 23 GRANTS Plaintiff’s motion. 24 25 PROCEDURAL BACKGROUND On April 20, 2017, Plaintiff and Dianne York-Goldman filed this action alleging 26 the following causes of action against Defendant in San Diego Superior Court: (1) breach 27 of contract; (2) breach of the covenant of good faith and fair dealing; (3) fraud; (4) unjust 28 enrichment and/or quantum meruit; (5) unfair competition in violation of California 1 17cv1124-MMA (WVG) 1 Business Code § 17200 et seq.; and (6) intentional interference with prospective 2 economic relations. See Doc. No. 1, Exhibit A (“Compl.”). On June 2, 2017, Defendant 3 filed a notice of removal based on diversity jurisdiction in this Court. See Doc. No. 1. 4 Defendant subsequently moved to dismiss all claims brought by Dianne York-Goldman, 5 the first, second, third, fourth, and sixth causes of action, and the prayer for attorneys’ 6 fees, punitive damages, and disgorgement of profits. Doc. No. 4. The Court granted in 7 part and denied in part Defendant’s motion. Doc. No. 10. Specifically, the Court 8 dismissed without prejudice the second, fourth, and sixth causes of action, the prayer for 9 attorneys’ fees, and all claims brought by Dianne York Goldman, and dismissed with 10 prejudice the third cause of action for fraud and the prayer for punitive damages. Id. at 11 15. 12 On November 14, 2017, Plaintiff filed the operative Second Amended Complaint 13 (“SAC”), alleging only breach of contract. Doc. No. 12 (“SAC”). Defendant answered 14 on November 28, 2017. Doc. No. 15. The Court held an Early Neutral Evaluation and 15 Case Management Conference and subsequently issued a Scheduling Order. See Doc. 16 Nos. 18, 19, 24 (“Scheduling Order”). The Scheduling Order set May 1, 2018 as the 17 deadline to amend pleadings or add parties, June 18, 2018 as the deadline to conduct fact 18 discovery, and August 27, 2018 for expert discovery. Scheduling Order at 1-2. 19 On June 7, 2018, Defendant’s counsel filed a motion to withdraw as counsel, citing 20 to unreasonable difficulty due to Defendant’s refusal to participate in the litigation. Doc. 21 No. 27. Defendant purportedly retained new counsel on May 2, 2018 who planned to file 22 a notice of appearance within two weeks. See Doc. No. 27-2 (“Brucker Decl.”) ¶ 5. 23 Accordingly, the Court granted the motion to withdraw and ordered Defendant to enter an 24 appearance of new counsel on or before August 1, 2018. Doc. No. 30. By October 26, 25 2018, Defendant had not entered an appearance of new counsel. See Docket. 26 Accordingly, the Court issued an order to show cause why sanctions should not issue for 27 Defendant’s failure to enter the appearance of new counsel and noted that failure to 28 2 17cv1124-MMA (WVG) 1 respond to the order may result in the Clerk’s entry of default. Doc. No. 34. The Court 2 gave Defendant until November 16, 2018 to respond. Id. 3 On November 9, 2018, Plaintiff filed an ex parte motion to amend the scheduling 4 order and a motion for leave to file a TAC. Doc. Nos. 38, 39. Plaintiff sought leave to 5 file a TAC to add claims for trademark infringement, breach of contract, and 6 misappropriation of Dianne York-Goldman’s name, thereby adding Dianne York- 7 Goldman back as a plaintiff in this action. Mtn. at 2. On November 15, 2018, Defendant 8 entered an appearance of new counsel, and the next day responded to the Court’s order to 9 show cause. Doc. Nos. 41, 43. As a result, the Court vacated the order to show cause. 10 Doc. No. 44. On December 12, 2018, the Court denied Plaintiff’s request to extend the 11 deadline to amend the pleadings and denied Plaintiff’s first motion for leave to file a 12 TAC. Doc. No. 49. On March 22, 2019, the Court issued a second amended scheduling 13 order, extending the fact discovery deadline to April 23, 2019 and the expert discovery 14 deadline to June 17, 2019. Doc. No. 76. The amended scheduling order did not move the 15 deadline to amend the pleadings. See id. Now, Plaintiff seeks for the second time leave 16 to file a TAC. Mtn. 17 LEGAL STANDARD 18 Once the district court issues a pretrial scheduling order establishing the deadline 19 for the amendment of pleadings, motions to amend filed after the deadline are governed 20 by Federal Rule of Civil Procedure 16 rather than Rule 15. See Johnson v. Mammoth 21 Recreations, Inc., 975 F.2d 604, 609 (9th Cir. 1992). “Although Rule 15(a) sets the 22 standard for determining when to allow a motion to amend a pleading, [Rule 16(b)] 23 requires that when a scheduling order must be modified, ‘good cause’ be shown.” Cano 24 v. Schriro, 236 F.R.D. 437, 439 (D. Ariz. 2006) (citing Johnson, 975 F.2d at 608). “A 25 court’s evaluation of good cause is not coextensive with an inquiry into the propriety of 26 amendment under . . . Rule 15.” Johnson, 975 F.2d at 609 (internal quotation marks and 27 citation omitted). “Unlike Rule 15(a)’s liberal amendment policy which focuses on the 28 bad faith of the party seeking to interpose an amendment and the prejudice to the 3 17cv1124-MMA (WVG) 1 opposing party, Rule 16(b)’s ‘good cause’ standard primarily considers the diligence of 2 the party seeking the amendment.” Id. If the moving party was not diligent, the inquiry 3 should end. Id. In other words, “the focus of the inquiry is upon the moving party’s 4 reasons for seeking modification.” Morgal v. Maricopa Cnty. Bd. of Supervisors, 284 5 F.R.D. 452, 460 (D. Ariz. 2012) (internal quotation marks and citation omitted). 6 DISCUSSION Plaintiff seeks to “include new allegations of [Defendant’s] additional breaches of 7 8 contract at issue in this case and ensuing damages.” Mtn. at 2. Plaintiff explains that 9 “[f]rom the new discovery obtained by [Plaintiff], it has learned that [Defendant] has 10 further breached the contract at issue in this case by not paying for inventory [Defendant] 11 sold and destroying some or all of the unsold inventory after termination in violation of 12 the Sales Agreement.” Id. at 4. Defendant opposes amendment, arguing Plaintiff knew 13 of facts underlying the proposed amendment since at least October 2017 and that 14 amendment would unduly prejudice Defendant. Oppo. at 3. 15 A. 16 Good Cause to Modify the Scheduling Order “[T]o demonstrate diligence under Rule 16’s ‘good cause’ standard, the movant 17 may be required to show the following: (1) that [it] was diligent in assisting the Court in 18 creating a workable Rule 16 order; (2) that [its] noncompliance with a Rule 16 deadline 19 occurred or will occur notwithstanding [its] diligent efforts to comply, because of the 20 development of matters which could not have been reasonably foreseen or anticipated at 21 the time of the Rule 16 scheduling conference; and (3) that [it] was diligent in seeking 22 amendment of the Rule 16 order, once it became apparent that [the movant] could not 23 comply with the order.” Jackson v. Laureate, Inc., 186 F.R.D. 605, 608 (E.D. Cal. 1999) 24 (internal citations omitted). 25 As indicated previously, the Scheduling Order mandated that motions to amend the 26 pleadings be filed on or before May 1, 2018. Doc. No. 24 at 1. Also, there is nothing to 27 suggest Plaintiff was not “diligent in assisting the Court in creating a workable Rule 16 28 order.” Jackson, 186 F.R.D. at 608. Therefore, the first good cause factor is met. 4 17cv1124-MMA (WVG) 1 Plaintiff contends the second good cause factor is met because it made diligent 2 efforts to comply with the deadline to amend the pleadings, but it could not have foreseen 3 or anticipated the new information it learned in March of 2019. See generally, Mtn.; 4 Reply. Specifically, Plaintiff asserts it did not discover facts supporting additional 5 breaches for nonpayment of royalties and destruction of Vitaphenol product until after 6 Defendant’s delay in responding to discovery and after Plaintiff took the deposition of 7 third parties. Mtn. at 5-6. In opposition, Defendant contends Plaintiff knew of the facts 8 supporting Plaintiff’s amendment as early as October of 2017. Oppo. at 3. Defendant 9 quotes a portion of a prior order stating “Plaintiffs assert that Avidas breached the 10 Contract by selling Vitaphenol products after representing to Plaintiffs that the remaining 11 stock of Vitaphenol products had expired and were disposed of.” Id. (quoting Doc. No. 12 10 ta 10). 13 While Plaintiff knew Defendant would “dispose of stock,” and that “all sales from 14 the stock disposal shall be subject to royalties,” it did not know “the products were going 15 to be destroyed.” Reply at 3 (quoting Doc. No. 47-2, Exhibit O). It wasn’t until March 16 11, 2019 that Plaintiff learned “two new things” warranting amendment of its Complaint: 17 (1) Defendant “licensed all of its obligations regarding the Vitapehnol products to 18 SciDerma Medical” and Defendant never paid Plaintiff” the amounts owed in connection 19 with SciDerma Medical’s purchase” of $300,000 worth of Vitaphenol Product; and (2) 20 Defendant “destroyed [the Vitaphenol inventory] after the termination date.” Reply at 2- 21 3. Plaintiff explains that two days after the Court issued an amended scheduling order 22 extending the discovery deadline, Plaintiff served requests for production of documents. 23 Doc. No. 77-2 at 2. On February 14, 2019, Defendant produced documents which 24 contained an email between Defendant and SciDerma Medical, LLC that vaguely 25 referenced products being destroyed. Id. at 5. Thus, Plaintiff deposed a principal of 26 SciDerma Medical, LLC on March 11, 2019, where the deponent testified that “at some 27 point after May 2014, he instructed the company where SciDerma Medical’s Vitaphenol 28 inventory was located (EPI Printers, Inc.) to destroy the inventory” and that “SciDerma 5 17cv1124-MMA (WVG) 1 Medical, LLC paid in excess of $300,000 to [Defendant] in 2010 for over 22,000 units of 2 Vitaphenol inventory.”1 Id. Plaintiff was unaware of the $300,000 purchase because 3 Defendant’s “accounting records do not reflect [Defendant] paying [Plaintiff] royalties 4 for that purchase.” Id. On March 14, 2019, Plaintiff issued a subpoena to EPI Printers, 5 Inc. for a deposition and production of documents set for March 27, 2019 to determine 6 what happened to the inventory. Id. At the deposition, Plaintiff learned that EPI Printers, 7 Inc. “destroyed over 11,000 units of Vitaphenol products” after Defendant notified 8 Plaintiff it was terminating the agreements as of July 11, 2014. Doc. No. 84-1 at 2. 9 Plaintiff diligently attempted to comply with the deadline to amend the pleadings, 10 but due to unforeseen complications—including the length of time Defendant was 11 unrepresented by counsel and various discovery issues2—Plaintiff did not learn 12 information regarding additional breaches of contract until March 11, 2019. 13 Accordingly, Plaintiff satisfies the second good cause factor. Plaintiff also asserts it was 14 diligent in filing this motion because it “made this motion as soon as reasonably possible 15 after discovering the need for the proposed amendment.” Mtn. at 6. The Court concludes 16 Plaintiff diligently sought amendment by filing the instant motion within two weeks of 17 discovering the information regarding the alleged additional breaches. 18 Based on the foregoing, the Court finds that Plaintiff has shown good cause to 19 modify the scheduling order. 20 B. 21 Leave to File an Amended Complaint Upon a showing of good cause to modify the scheduling order, a party seeking 22 amendment of its pleading must then demonstrate that a court should grant leave under 23 Rule 15. Johnson, 975 F.2d at 608. Under Rule 15(a) of the Federal Rules of Civil 24 25 26 27 28 Defendant appears to argue that its responses to Plaintiff’s interrogatories show the proposed amendment is factually inaccurate. However, the responses merely assert that as of July 11, 2014 Defendant did not have any Vitaphenol products or inventory. Doc. No. 83-2 at 2. 2 Defendant was unrepresented from July 5, 2018, until November 15, 2018. See Doc. Nos. 30, 41. Additionally, the docket reflects various discovery issues. See Doc. Nos. 55-76, 78-82. 1 6 17cv1124-MMA (WVG) 1 Procedure, “the decision of whether to grant leave to amend . . . remains within the 2 discretion of the district court, which may deny leave to amend due to ‘undue delay, bad 3 faith or dilatory motive on the part of the movant, repeated failure to cure deficiencies by 4 amendments previously allowed, undue prejudice to the opposing party by virtue of 5 allowance of the amendment, [and] futility of amendment.’” Leadsinger, Inc. v. BMG 6 Music Publ’g, 512 F.3d 522, 532 (9th Cir. 2008) (quoting Foman v. Davis, 371 U.S. 178, 7 182 (1962)). 8 9 In opposition to Plaintiff’s motion, Defendant argues that permitting amendment would “unduly prejudice” it. Oppo. at 3. Defendant does not challenge any of the other 10 Foman factors. See id. However, the Court finds the other factors are satisfied. First, 11 Plaintiff filed its motion within two weeks of discovering information underlying the 12 proposed amendment. As a result, there is an insufficient showing of undue delay. 13 Second, there is no indication of wrongful motive in Plaintiff amending the complaint. 14 Third, Plaintiff has not previously amended the complaint other than omitting dismissed 15 causes of action following the Court’s order granting in part Defendant’s motion to 16 dismiss. See Docket. As to the fifth factor, Defendant does not allege amendment would 17 be futile or legally insufficient. See Oppo. The Court, therefore, turns to prejudice. 18 Defendant argues in three sentences that amendment would be unduly prejudicial. 19 Id. at 3. Specifically, Defendant argues this motion is an “attempt to restart this litigation 20 based on nothing[.]” Id. As an initial matter, the Court notes that Plaintiff has declared 21 that new discovery factually supports its allegations and that Defendant did not argue 22 amendment would be futile. This suggests that the motion is not “based on nothing.” 23 While the Court recognizes that this case was originally filed in this Court in June 2017, 24 there have been several complications, including, as noted above, a period of time where 25 Defendant was unrepresented by counsel and several discovery issues. See Docket. Due 26 to these complications, “little discovery” had been done by November 2018. See Doc. 27 No. 39-1 at 5. Since the amended scheduling order issued in January 2019, there have 28 been several discovery disputes. See Docket. Moreover, as noted by Plaintiff, the 7 17cv1124-MMA (WVG) 1 dispositive motion deadline is set for July 15, 2019 and a trial date has not yet been 2 scheduled. Mtn. at 7. Based on the procedural posture of the case and due to its 3 complications with representation and discovery disputes, the Court finds that 4 amendment would not be unduly prejudicial. 5 CONCLUSION 6 As indicated above, Plaintiff has met the requirements of Federal Rules of Civil 7 Procedure 15(a) and 16(b). Accordingly, the Court GRANTS Plaintiff’s motion. The 8 Clerk of Court is instructed to file Plaintiff’s proposed Third Amended Complaint (Doc. 9 No. 77-7) as a separate docket entry. 10 IT IS SO ORDERED. 11 Dated: April 29, 2019 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 8 17cv1124-MMA (WVG)

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?